Friday 29/11/2024 h. 2.00 pm - Hybrid seminar Silvia Giatti, Unit of Neuroendocrinology, University of Milan New insights into the post-SSRI sexual dysfunction (PSSD) syndrome Antidepressants are a widely prescribed class of drugs used to treat mood disorders such as depression, anxiety, premenstrual dysphoric disorder, and post-traumatic stress disorder. Among the various types of antidepressants, selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the most commonly used. Despite their effectiveness, these medications are often associated with side effects, with sexual dysfunction being one of the most frequently reported issues. This side effect can negatively impact patients’ adherence to therapy and reduce overall quality of life, leading to treatment discontinuation in some patients. Notably, some patients continue to experience sexual dysfunction even after discontinuing SSRIs/SNRIs, or they may develop new sexual issue...
